NIST has released forensic DNA reference material RM 8043, and for the first time the package includes degraded DNA and mixtures from more than two individuals. The kit contains eight vials: six hold high-quality DNA from single donors or mixtures of two or three people, and two hold degraded DNA from two of those same individuals. The agency released the material in late December after distributing it to roughly 100 forensic laboratories for pre-release validation.

The release addresses a measurement gap that has widened as DNA profiling hardware has grown more sensitive. Modern forensic instruments detect trace amounts of DNA — on the order of half a nanogram to one nanogram per test — which means labs now routinely process samples that older reference materials never represented. NIST's existing genetic reference materials use relatively pristine DNA, undamaged by environmental exposure, and none contain mixtures of more than two people.

Crime-scene evidence rarely cooperates. Genetic material left at a scene often comes from several people, and it degrades through time or exposure to the elements. Interpreting a mixture or a degraded sample is materially harder than reading a clean single-source profile, and the risk of error rises when only trace quantities are present. That is the failure mode RM 8043 is built to catch: a lab runs the reference material through its workflow, compares the result against the NIST-supplied data sheet, and confirms — or corrects — its interpretation.

How NIST degraded the samples

Rather than collecting naturally degraded material, NIST researchers fragmented the DNA in a controlled, repeatable way: they irradiated the samples with ultraviolet light for a set amount of time. UV exposure breaks DNA strands, mimicking the fragmentation that occurs as genetic material ages or weathers in the environment. Because the degradation is controlled, the material offers a consistent benchmark rather than the variable damage found in real casework — the same trade-off a metrologist accepts with any calibrated artifact.

The DNA comes from anonymous individuals who consented to research use. Each vial contains close to 900 nanograms of DNA, roughly a factor of 900 more than the 0.5–1 ng a typical test consumes. NIST researcher Erica Romsos explained the rationale: "We've given laboratories a surplus of what they need, so that they can use the samples at many different times during DNA analysis or use them repetitively as part of a training set for forensic analysts."

Ground truth for instruments, software, and analysts

The accompanying data sheet lists the genetic profiles of the donors. That known-answer format lets labs apply the material across four distinct verification tasks: checking instrument accuracy, developing new genetic analysis methods, validating interpretation software, and training analysts. If a lab's analysis of the NIST samples matches the data sheet, its analysts gain confidence that they will correctly interpret DNA from an actual crime scene.

Peter Vallone, a NIST researcher specializing in DNA analysis, framed the material's role plainly: "These samples act as ground truth. Genetics laboratories can use the samples to kick the tires and make sure that a new instrument or technology is working as it should."

That framing matters for procurement as much as for casework. A lab evaluating a new capillary electrophoresis system, a new short-tandem-repeat kit, or probabilistic-genotyping software can now qualify the tool against mixtures and degraded templates — the sample classes that actually dominate difficult casework — rather than against pristine single-source DNA that flatters the instrument.

The development sits within NIST's Forensic Science Research Program, which spans forensic genetics, fingerprint analysis, ballistics, digital forensics, and forensic chemistry. The program's stated aim is accuracy in results that carry consequences for crime victims, their families, and the accused.

The question RM 8043 raises for laboratory managers is one of adoption: will labs incorporate mixture and degraded-DNA reference checks into their routine quality assurance and analyst qualification protocols, or reserve the material for one-time instrument validation? Given that the pre-release round reached about 100 laboratories, the demand clearly exists. Whether accreditation bodies and standard-setting organizations now formalize requirements for routine testing against challenging sample types will determine how far this ground truth travels.